William H. Frishman

1.3k total citations
71 papers, 774 citations indexed

About

William H. Frishman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, William H. Frishman has authored 71 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 11 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in William H. Frishman's work include Blood Pressure and Hypertension Studies (10 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). William H. Frishman is often cited by papers focused on Blood Pressure and Hypertension Studies (10 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). William H. Frishman collaborates with scholars based in United States, Iran and India. William H. Frishman's co-authors include Eliot J. Lazar, Brian R. Landzberg, M. Dror Michaelson, Mitchell C. Weiser, Judith E. Soberman, Joseph Conigliaro, Steven M. Greenberg, Jennifer Sugg, Edgar Lichstein and Shlomo Charlap and has published in prestigious journals such as Circulation, The American Journal of Medicine and The American Journal of Cardiology.

In The Last Decade

William H. Frishman

50 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William H. Frishman United States 16 419 160 122 86 76 71 774
Flavia Franconi Italy 12 339 0.8× 137 0.9× 93 0.8× 120 1.4× 79 1.0× 21 878
Miyuki Tsuchihashi Japan 11 561 1.3× 178 1.1× 91 0.7× 109 1.3× 124 1.6× 16 1.1k
Maria Virginia Manzi Italy 16 412 1.0× 106 0.7× 168 1.4× 79 0.9× 79 1.0× 62 789
Elena Blasco‐Colmenares United States 17 544 1.3× 139 0.9× 93 0.8× 84 1.0× 39 0.5× 27 991
Manolis S. Kallistratos Greece 17 768 1.8× 195 1.2× 180 1.5× 123 1.4× 98 1.3× 66 1.4k
Robert Hogikyan United States 16 390 0.9× 102 0.6× 96 0.8× 58 0.7× 169 2.2× 38 752
Caroline Weytjens Belgium 16 529 1.3× 128 0.8× 99 0.8× 71 0.8× 55 0.7× 43 1.0k
Raktim K. Ghosh United States 20 400 1.0× 266 1.7× 208 1.7× 203 2.4× 75 1.0× 54 1.1k
Andrea Ferrucci Italy 17 671 1.6× 130 0.8× 189 1.5× 52 0.6× 81 1.1× 63 916
Franz H. Messerli United States 13 542 1.3× 162 1.0× 224 1.8× 72 0.8× 40 0.5× 24 889

Countries citing papers authored by William H. Frishman

Since Specialization
Citations

This map shows the geographic impact of William H. Frishman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Frishman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Frishman more than expected).

Fields of papers citing papers by William H. Frishman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Frishman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Frishman. The network helps show where William H. Frishman may publish in the future.

Co-authorship network of co-authors of William H. Frishman

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Frishman. A scholar is included among the top collaborators of William H. Frishman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Frishman. William H. Frishman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frishman, William H., et al.. (2025). Sugar-Free but Not Risk-Free? Exploring Artificial Sweeteners and Cardiovascular Disease. Cardiology in Review. 2 indexed citations
2.
3.
Moradi, Mohammad, et al.. (2025). Coronary Collaterals: A Comprehensive Review. Cardiology in Review.
4.
James, Maggie, et al.. (2025). Inflammation-Driven Arrhythmias: Bridging Immunology and Electrophysiology. Cardiology in Review.
5.
Parikh, Manish A., et al.. (2025). Cardiac Cachexia: A Comprehensive Review. Cardiology in Review.
6.
Frishman, William H., et al.. (2025). Genetic Risk of Peripartum Cardiomyopathy: An Updated Narrative Review of the Pre-Clinical and Clinical Literature. Cardiology in Review. 1 indexed citations
7.
8.
Frishman, William H., et al.. (2024). Thomas Killip III: A Tribute to a Leader in Academic Cardiology and a Pioneer of the Acute Coronary Care Unit. Cardiology in Review. 33(1). 1–3.
9.
Frishman, William H., et al.. (2008). Stem Cell Therapy for the Kidney?. American Journal of Therapeutics. 16(3). 247–256. 21 indexed citations
10.
11.
Papademetriou, Vasilios, et al.. (2005). Metoprolol succinate extended release: Antihypertensive dose response characteristics. American Journal of Hypertension. 18(5). A88–A88. 1 indexed citations
12.
Weiser, Mitchell C., et al.. (1997). The Pharmacologic Approach to the Treatment of Obesity. The Journal of Clinical Pharmacology. 37(6). 453–473. 56 indexed citations
13.
14.
Podrid, Philip J., et al.. (1991). Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine. The American Journal of Cardiology. 68(17). 1662–1667. 7 indexed citations
15.
Wallin, John D. & William H. Frishman. (1989). Dilevalol: A Selective Beta‐2 Adrenergic Agonist Vasodilator with Beta Adrenergic Blocking Activity. The Journal of Clinical Pharmacology. 29(12). 1057–1068. 9 indexed citations
16.
Frishman, William H.. (1989). New Therapeutic Modalities in Hypertension: Focus on a New Calcium Antagonist—Nicardipine. The Journal of Clinical Pharmacology. 29(6). 481–487. 20 indexed citations
17.
Charlap, Shlomo, Edgar Lichstein, & William H. Frishman. (1989). β-Adrenergic Blocking Drugs in the Treatment of Congestive Heart Failure. Medical Clinics of North America. 73(2). 373–385. 10 indexed citations
18.
Charlap, Shlomo, et al.. (1989). Electromechanical dissociation: Diagnosis, pathophysiology, and management. American Heart Journal. 118(2). 355–360. 13 indexed citations
19.
Frishman, William H., et al.. (1987). β-Adrenergic Blockade in Children. Cardiology Clinics. 5(4). 629–649. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Flavia Franconi Breakdown of academic impact, for papers by Miyuki Tsuchihashi Breakdown of academic impact, for papers by Maria Virginia Manzi Breakdown of academic impact, for papers by Elena Blasco‐Colmenares Breakdown of academic impact, for papers by Manolis S. Kallistratos Breakdown of academic impact, for papers by Robert Hogikyan Breakdown of academic impact, for papers by Caroline Weytjens Breakdown of academic impact, for papers by Raktim K. Ghosh Breakdown of academic impact, for papers by Andrea Ferrucci Breakdown of academic impact, for papers by Franz H. Messerli
Rankless by CCL
2026